A case-control study to assess possible triggers and cofactors in chronic fatigue syndrome

American Journal of Medicine

Volumn 100, Issue 5, 1996, Pages 548-554

  MacDonald, Kristine L ^a   Osterholm, Michael T ^a   LeDell, Kathleen H ^a   White, Karen E ^a   Schenck, Carlos H ^a   Chao, Chun C ^a   Persing, David H ^b   Johnson, Russell C ^a   Barker, James M ^c   Peterson, Phillip K ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b MAYO CLINIC   (United States)

^c Aspen Medical Group   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY; CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; PROTOZOON ANTIBODY; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; AGED; ALLERGY; ARTICLE; BABESIA MICROTI; BORRELIA BURGDORFERI; BREAST PROSTHESIS; CASE CONTROL STUDY; CHRONIC FATIGUE SYNDROME; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; EXERCISE; FEMALE; HUMAN; MALE; NULLIPARA; PRIORITY JOURNAL; QUESTIONNAIRE; SILICONE PROSTHESIS;

EID: 0029943057     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(96)00017-4     Document Type: Article

References (45)

1. Levy JA. Part III: Viral studies of chronic fatigue syndrome. Introduction. Clin Infect Dis. 1994;18(suppl 1):S117-S120.
2. Landay AL, Jessop C, Lennett ET, Levy JA. Chronic fatigue syndrome: clinical condition associated with immune activation. Lancet. 1991;338:707-712.
3. Prieto J, Subir ML, Castilla A, Serrano M. Naloxone *reversible monocyte dysfunction in patients with chronic fatigue syndrome. Scand J Immunol. 1989;30:13-20.
4. Buchwald D, Komaroff AL. Review of laboratory findings for patients with chronic fatigue syndrome. Rev Infect Dis. 1991;13(suppl 1):S12-S18.
5. Gupta S, Vayuvegula B. A comprehensive immunological analysis in chronic fatigue syndrome. Scand J lmmunol. 1991;33:319-327.
6. Patarca R, Klimas NG, Lugtendorf S, et al. Dysregulated expression of tumor necrosis factor in chronic fatigue syndrome: interrelations with cellular sources and patterns of soluble immune mediator expression. Clin Infect Dis. 1994;18(suppl 1):S147-S153.
7. Klimas NG, Salvato FR, Morgan R, Fletcher MA. Immunologic abnormalities in chronic fatigue syndrome. J Clin Microbiol. 1990;28:1403-1410.
8. Holmes GP, Kaplan JE, Stewart JA, et al. A cluster of patients with a chronic mononucleosis-like syndrome. JAMA. 1987;257:2297-2302.
9. Sumaya CV. Serologic and virologic epidemiology of Epstein-Barr virus: relevance to chronic fatigue syndrome. Rev Infect Dis. 1991:13(suppl 1):S19-S25.
10. Straus SE, Tosato G, Armstrong G, et al. Persisting illness and fatigue in adults with evidence of Epstein-Barr virus infection. Ann Intern Med. 1985;102:7-16.
11. Jones JF, Ray G, Minnich LL, et al. Evidence for active Epstein-Barr virus infection in patients with persistent, unexplained illnesses: elevated anti-early antigen antibodies. Ann Intern Med. 1985;102:1-7.
12. Wakefield D, Lloyd A, Dwyer J, Salahuddin SZ, Ablashi DV. Human herpes-virus 6 and myalgic encephalomyelitis. Lancet. 1988;1:1059.
13. Evans AC. Brucellosis in the United States. Am J Public Health. 1947;37:139-151.
14. Cluff LE, Trever RW, Imboden JB, Canter A. Brucellosis II. Medical Aspects of delayed convalescence. Arch Intern Med. 1959;103:398-405.
15. Gow JW, Behan WMH, Simpson K, et al. Studies on enterovirus in patients with chronic fatigue syndrome. Clin Infect Dis. 1994;18(suppl 1):S126-S129.
16. Chester AC, Levine PH. Concurrent sick building syndrome and chronic fatigue syndrome: epidemic neuromyasthenia revisited. Clin Infect Dis. 1994;18(suppl 1):S43-S48.
17. Straus SE, Dale JK, Wright R, Metcalfe DD. Allergy and the chronic fatigue syndrome. J Allergy Clin lmmunol. 1988;81:791-795.
18. Wessely S, Powell R. Fatigue syndromes: a comparison of chronic 'post-viral' fatigue with neuromuscular and affective disorders. J Neurol Neurosurg Psychiatry. 1989;52:940-948.
19. Wood GC, Bental RP, Gopfert M, Edwards RH. A comparative psychiatric assessment of patients with chronic fatigue syndrome and muscle disease. Psychol Med. 1991;21:619-628.
20. Kruesi MJP, Dale J, Straus SE. Psychiatric diagnoses in patients who have chronic fatigue syndrome. J Clin Psychiatry. 1989;50:53-56.
21. Steketete RW, Eckman MR, Burgess EC, et al. Babesicsis in Wisconsin. A new focus of disease transmission. JAMA. 1985;253:2675-2678.
22. Osterholm MT, Forfang JC, White KE, et al. Lyme disease in Minnesota: Epidemiologic and serologic findings. Yale J Biol Med. 1984;57:677-683.
23. Krause P, Sikand VJ, Telford S, et al. Molecular monitoring of Babesia microti parasitemia: evidence of chronic infection in humans. Presented at the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology; October 4-7, 1992. Orlando, Fla. Abstract M43:200.
24. Shadick NA, Phillips CB, Logigian EL, et al. The long-term clinical outcomes of Lyme disease. A population-based retrospective cohort study. Ann Intern Med. 1994;121:560-567.
25. Solomon G, Espinoza L, Silverman S. Breast implants and connective tis-sue diseases. NEJM. 1994;331:1231. Letter.
26. Solomon G. A clinical and laboratory profile of symptomatic women with silicone breast implants. Semin Arthritis Rheum. 1994;24:29-37.
27. Peterson PK, Schenck CH, Sherman R. Chronic fatigue syndrome in Minnesota. Minn Med. 1991;74:21-26.
28. Holmes GP, Kaplan JE, Gantz NM, et al. Chronic fatigue syndrome: a working case definition. Ann Intern Med. 1988;108:387-389.
29. Beck AT, Steer RA, Garbin MG. Psychometric properties of the Beck Depression Inventory: twenty-five years of evaluation. Clin Psychol Rev. 1988;8:77-100.
30. Zung WWK. A rating instrument for anxiety disorders. Psychosomatics. 1971;12:371-379.
31. Derogatis LR. SCL-90-R (administration, scoring & procedures manual -II). Towson, Md. Clin Psychometric Res 1983.
32. Chao CC, Janoff EN, Hu S, et al. Altered cytokine release in peripheral blood mononuclear cell cultures from patients with the chronic fatigue syndrome. Cytokine. 1991;3:292-298.
33. Engstrom SM, Shoop E, Johnson RC. Immunoblot interpretation criteria for serodiagnosis of early Lyme disease. J Clin Micro. 1995;33:419-427.
34. Krause PJ, Telford III SR, Ryan R, et al. Diagnosis of babesiosis: evaluation of a serologic test for the detection of Babesia microti antibody. J Infect Dis. 1994;169:923-926.
35. Persing DH, Herwaldt BL, Glaser C; et al. Zoonotic infection with a Babesia-like piroplasm in the western United States. NEJM. In press.
36. Fleiss JL. Statistical methods for rates and proportions. New York: Wiley & Sons; 1973:77-83.
37. Rosner, Bernard. Fundamentals of Biostatistics. Boston: Prindle, Weber and Schmidt, 1986:283-293.
38. Khan AS, Heneine WM, Chapman LE, et al. Assessment of a retrovirus sequence and other possible risk factors for the chronic fatigue syndrome in adults. Ann Intern Med. 1993;118:241-245.
39. Bell KM, Cookfair D, Bell DS, et al. Risk factors associated with chronic fatigue syndrome in a cluster of pediatric cases. Rev Infect Dis. 1991:13(suppl 1):S32-S38.
40. Chao CC, Peterson PK. Exercise and the pathogenes s of infectious disease. The AIDS Reader. 1993; May/June:77-83.
41. Abbey SE, Garfinkel PE. Chronic fatigue syndrome and depression: cause, effect, or covariate. Rev Infect Dis. 1991;13(suppl 1):S73-S83.
42. Coyle PK, Krupp LB, Doscher C, Amin K. Borrelia burgdorferi reactivity in patients with severe persistent fatigue who are from a region in which Lyme disease is endemic. Clin Infect Dis. 1994;18(suppl 1):S24-S27.
43. Katon WJ, Buchwald DS, Simon GE, et al. Psychiatric illness in patients with chronic fatigue and those with rheumatoid arthritis. J Gen Intern Med. 1991;6:277-285.
44. Clark MR, Katon W, Russo J, et al. Chronic fatigue: Risk factors for symptom persistence in a 2 1/2-year follow-up study. Am J (Med. 1995;98:187-195.
45. Shafran SD. The chronic fatigue syndrome. Am J Med. 1991;90:730-739.